Skip to main content

and
  1. Article

    Erratum: Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study

    Correction to: Eye (2013), 27, 709–715; doi:10.1038/eye.2013.8; published online 1 March 2013 Since the publication of the above article, it has been noted that a line appeared incorrectly between RETREATMENT ...

    A Tufail, P J Patel, S Sivaprasad, W Amoaku, A C Browning, M Cole, R Gale, S George in Eye (2014)

  2. Article

    Erratum: Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study

    Correction to: Eye (2013) 27, 709–715; doi:10.1038/eye.2013.8; published online 1 March 2013 Since online publication of the above article, the authors have noted that the names of the fifth and ninth authors ...

    A Tufail, P J Patel, S Sivaprasad, W Amoaku, A C Browning, M Cole, R Gale, S George in Eye (2013)

  3. Article

    Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study

    To evaluate the efficacy and safety of intravitreal ranibizumab in patients with choroidal neovascularisation secondary to pathological myopia (myopic CNV). Data are from a pre-planned, 6-month interim analysis.

    A Tufail, P J Patel, S Sivaprasad, W Amoaku, A C Browning, M Cole, R Gale, S George in Eye (2013)

  4. Article

    A case of postoperative candida endophthalmitis

    R Lagnado, R Gupta, A Osborne, H S Dua in Eye (2005)